83 related articles for article (PubMed ID: 28483518)
41. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P
J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632
[TBL] [Abstract][Full Text] [Related]
42. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
[TBL] [Abstract][Full Text] [Related]
43. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
[TBL] [Abstract][Full Text] [Related]
44. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway.
Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q
Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278
[TBL] [Abstract][Full Text] [Related]
45. Anti-proliferative and pro-apoptotic activities of Alpinia oxyphylla on HepG2 cells through ROS-mediated signaling pathway.
Zhang Q; Cui C; Chen CQ; Hu XL; Liu YH; Fan YH; Meng WH; Zhao QC
J Ethnopharmacol; 2015 Jul; 169():99-108. PubMed ID: 25891473
[TBL] [Abstract][Full Text] [Related]
46. Piper nigrum ethanolic extract rich in piperamides causes ROS overproduction, oxidative damage in DNA leading to cell cycle arrest and apoptosis in cancer cells.
de Souza Grinevicius VM; Kviecinski MR; Santos Mota NS; Ourique F; Porfirio Will Castro LS; Andreguetti RR; Gomes Correia JF; Filho DW; Pich CT; Pedrosa RC
J Ethnopharmacol; 2016 Aug; 189():139-47. PubMed ID: 27178634
[TBL] [Abstract][Full Text] [Related]
47. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
48. Molecular links among non-biodegradable nanoparticles, reactive oxygen species, and autophagy.
Anozie UC; Dalhaimer P
Adv Drug Deliv Rev; 2017 Dec; 122():65-73. PubMed ID: 28065863
[TBL] [Abstract][Full Text] [Related]
49. Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy.
Wang S; Zhang J; Li W; Chen D; Tu J; Sun C; Du Y
Carbohydr Polym; 2022 Nov; 296():119940. PubMed ID: 36087989
[TBL] [Abstract][Full Text] [Related]
50. The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis.
Zhang Y; Li J; Zhong H; Xiao X; Wang Z; Cheng Z; Hu C; Zhang G; Liu S
Cell Death Discov; 2021 Sep; 7(1):268. PubMed ID: 34588425
[TBL] [Abstract][Full Text] [Related]
51. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-6. Burkitt lymphoma (BL).
Ishizawa K
Int J Hematol; 2019 Sep; 110(3):265-271. PubMed ID: 31297687
[No Abstract] [Full Text] [Related]
52. High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiation.
Minai L; Yeheskely-Hayon D; Yelin D
Sci Rep; 2013; 3():2146. PubMed ID: 23828378
[TBL] [Abstract][Full Text] [Related]
53. [Burkitt lymphoma: BL].
Ishizawa K
Rinsho Ketsueki; 2019; 60(3):243-244. PubMed ID: 31068531
[No Abstract] [Full Text] [Related]
54. [Effects of L-asparaginase on proliferation, cell cycle and apoptosis of Burkitt lymphoma cell lines].
Tu DY; Zhang M; Yin WJ; Xu LY; Sang W; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):930-938. PubMed ID: 35045655
[No Abstract] [Full Text] [Related]
55. Activated STAT3 signaling pathway by ligature-induced periodontitis could contribute to neuroinflammation and cognitive impairment in rats.
Hu Y; Zhang X; Zhang J; Xia X; Li H; Qiu C; Liao Y; Chen H; He Z; Song Z; Zhou W
J Neuroinflammation; 2021 Mar; 18(1):80. PubMed ID: 33757547
[TBL] [Abstract][Full Text] [Related]
56. STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy.
Yang PL; Liu LX; Li EM; Xu LY
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872659
[TBL] [Abstract][Full Text] [Related]
57. [Mechanism of STAT3 phosphorylation mediated leukemia cells resistance to doxorubicin].
Jia ZX; Lu XZ; Cai XH; Qin W; Han WM; Xiao R; Zhou M; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):69-71. PubMed ID: 32023758
[No Abstract] [Full Text] [Related]
58. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.
Costea T; Vlad OC; Miclea LC; Ganea C; Szöllősi J; Mocanu MM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936346
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.
Al-Kawaaz M; Sanchez T; Kluk MJ
J Hematop; 2019 Jun; 12(2):57-65. PubMed ID: 31404445
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]